Palisade Capital Management LP Takes $9.64 Million Position in Integer Holdings Corporation $ITGR

Palisade Capital Management LP acquired a new position in Integer Holdings Corporation (NYSE:ITGR) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 103,179 shares of the medical equipment provider’s stock, valued at approximately $9,642,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Integer by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock worth $2,539,000 after purchasing an additional 837 shares in the last quarter. Millennium Management LLC boosted its holdings in Integer by 2,408.8% in the first quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after acquiring an additional 118,224 shares in the last quarter. Jones Financial Companies Lllp grew its stake in shares of Integer by 79,888.9% in the first quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock worth $850,000 after acquiring an additional 7,190 shares during the last quarter. United Services Automobile Association bought a new position in shares of Integer during the first quarter valued at $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Integer by 4.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock worth $12,900,000 after purchasing an additional 4,873 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Price Performance

Shares of NYSE:ITGR opened at $125.45 on Wednesday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.41 and a current ratio of 3.73. The firm has a market cap of $4.26 billion, a price-to-earnings ratio of 34.28, a price-to-earnings-growth ratio of 2.95 and a beta of 0.61. The business has a 50-day simple moving average of $105.49 and a two-hundred day simple moving average of $93.71. Integer Holdings Corporation has a fifty-two week low of $62.00 and a fifty-two week high of $126.14.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.38 by $0.22. Integer had a net margin of 6.97% and a return on equity of 12.79%. The firm had revenue of $464.11 million for the quarter, compared to the consensus estimate of $451.07 million. During the same quarter last year, the firm posted $1.55 EPS. The business’s quarterly revenue was down 2.6% compared to the same quarter last year. On average, analysts expect that Integer Holdings Corporation will post 6.09 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have weighed in on ITGR shares. Benchmark lowered shares of Integer from a “buy” rating to a “hold” rating in a research note on Thursday, August 13th. Zacks Research upgraded shares of Integer from a “strong sell” rating to a “hold” rating in a report on Monday, July 20th. Weiss Ratings reissued a “hold (c)” rating on shares of Integer in a research report on Thursday, June 18th. HC Wainwright restated a “buy” rating on shares of Integer in a report on Friday, July 24th. Finally, Piper Sandler cut Integer from an “overweight” rating to a “hold” rating and set a $127.00 price objective on the stock. in a research report on Monday, August 3rd. One investment analyst has rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $109.86.

Key Headlines Impacting Integer

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Zacks raised its fiscal 2026 EPS estimate to $6.13 from $6.05, above the current consensus estimate of $6.08. This improvement may be supporting investor confidence in Integer’s near-term earnings outlook. Integer Holdings analyst estimate update
• Positive Sentiment: The firm also modestly increased its Q2 2027 EPS estimate to $1.61 from $1.60 and Q1 2028 EPS to $1.71 from $1.65, indicating some confidence in selected periods of future growth. Integer Holdings earnings estimate revisions
• Neutral Sentiment: Zacks maintained a Hold rating on Integer. Its estimates imply EPS of $6.56 for fiscal 2027 and $6.85 for fiscal 2028, suggesting continued earnings growth but not enough conviction for a more bullish rating. Zacks rating on Integer Holdings
• Negative Sentiment: Zacks reduced estimates for Q3 and Q4 2026 EPS to $1.63 and $1.70, respectively, from $1.68 and $1.77. It also cut fiscal 2027 EPS to $6.56 from $6.87 and fiscal 2028 EPS to $6.85 from $7.20. These downward revisions point to a softer longer-term earnings trajectory and may weigh on valuation. Integer Holdings downward EPS revisions

Integer Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.